766513-53-5

Basic information

• Product Name: C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine
• Synonyms: C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine
• CAS NO: 766513-53-5
• Molecular Formula: C₇H₇F₃N₂
• Molecular Weight: 176.14
• Mol File: 766513-53-5.mol

Chemical Properties

• Boiling Point: 208°C at 760 mmHg
• Flash Point: 79.6°C
• Appearance: /
• Density: 1.293g/cm³
• Vapor Pressure: 0.219mmHg at 25°C
• Refractive Index: 1.466
• Storage Temp.: under inert gas (nitrogen or Argon) at 2–8 °C
• CAS DataBase Reference: C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine(CAS DataBase Reference)
• NIST Chemistry Reference: C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine(766513-53-5)
• EPA Substance Registry System: C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine(766513-53-5)

Safety Data

• Hazardous Substances Data: 766513-53-5(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine is used as a key intermediate in the synthesis of various biologically active molecules for the development of novel therapeutic agents. Its trifluoromethyl-pyridine group contributes to the enhancement of pharmacological effects, making it a promising candidate for the treatment of a wide range of diseases.
Used in Drug Discovery and Development:
C-(5-Trifluoromethyl-pyridin-3-yl)-methylamine serves as a valuable tool in drug discovery and development efforts due to its unique chemical structure and properties. It can be incorporated into drug molecules to improve their efficacy, selectivity, and pharmacokinetic profiles, thereby accelerating the process of identifying and optimizing potential drug candidates.

InChI:InChI=1/C7H7F3N2/c8-7(9,10)6-1-5(2-11)3-12-4-6/h1,3-4H,2,11H2

Upstream product

• 951624-83-2 5-(trifluoromethyl)pyridine-3-carbonitrile 
• 129904-48-9 2-hydroxy-5-(trifluoromethyl)nicotinaldehyde 
• 624734-22-1 2-chloro-5-(trifluoromethyl)pyridine-3-carbonitrile 

Downstream Products

• 1020747-80-1 3,3,3-trifluoro-2-hydroxy-2-phenyl-N-{[5-(trifluoromethyl)pyridin-3-yl]methyl}propanamide 

Relevant articles and documents

(3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING

The present invention provides novel beta-secretase inhibitors and methods for their use, including methods of treating of Alzheimer's disease. (Formula)

2-HYDROXY-2-PHENYL/THIOPHENYL PROPIONAMIDES AS ANDROGEN RECEPTOR MODULATORS

Compounds of structural formula (I) are modulators of the androgen receptor (AR) in a tissue selective manner. These compounds are useful in the enhancement of weakened muscle tone and the treatment of conditions caused by androgen deficiency or which can

TETRAHYDROPYRAN HETEROCYCLIC CYCLOPENTYL HETEROARYL MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

The present invention is further directed to compounds of the formulas: (I) (II) (wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R15, R16, R17, R18, R19, R24 and R25 are as defined herein) which are modulators of chemokine receptor activity and are useful in the prevention or treatment of certain inflammatory and immunoregulatory disorders and diseases, allergic diseases, atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma, as well as autoimmune pathologies such as rheumatoid arthritis and atherosclerosis. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which chemokine receptors are involved.